TY - JOUR
T1 - IL-10 deficiency leads to somatic mutations in a model of IBD
AU - Sato, Yuichirou
AU - Takahashi, Seiichi
AU - Kinouchi, Yoshitaka
AU - Shiraki, Manabu
AU - Endo, Katsuya
AU - Matsumura, Yoshifumi
AU - Kakuta, Yoichi
AU - Tosa, Masaki
AU - Motida, Atsuhiro
AU - Abe, Hiroko
AU - Imai, Go
AU - Yokoyama, Hiroshi
AU - Nomura, Eiki
AU - Negoro, Kenichi
AU - Takagi, Sho
AU - Aihara, Hiroyuki
AU - Masumura, Ken Ichi
AU - Nohmi, Takehiko
AU - Shimosegawa, Tooru
N1 - Funding Information:
We are deeply grateful to Prof. Tetsuya Ono for his appropriate advices on mouse experiments. This work was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science, and by the Kurokawa Cancer Foundation.
PY - 2006/5
Y1 - 2006/5
N2 - Individuals with inflammatory bowel disease (IBD) are at increased risk of developing gastrointestinal cancer. Here, we have tested the possibility that chronic inflammation could trigger mutations. For this, we have used IL-10-deficient (IL-10-/-) mice, which spontaneously develop intestinal inflammation, in combination with a transgenic gpt gene and red/gam gene (gpt+IL- 10-/-), which is a well-characterized mutation reporter locus. The total mutation frequency in the colon of gpt+IL- 10-/- mice was about five times higher than that in normal gpt+IL-10+/+ mice. In the particular case of G:C to A:T transitions, the frequency of mutations in gpt+IL- 10-/- mice was 4.1 times higher than that in control mice. Interestingly, the frequency of small deletions and insertions was also strikingly increased (∼10 times). The majority of the deletion or insertion mutations were observed in the monotonous base runs or adjacent repeats of short tandem sequences. In contrast, the frequency of large deletions, detected by loss of the Spi marker present in the red/gam transgene, was similar among the mouse strains. Finally, as a control, the mutation frequency in non-inflamed tissues, such as the liver, were similar between gpt+IL-10-/- mice and gpt+IL-10+/+ mice. Our data demonstrate that the chronic inflammatory environment in the colon promotes the generation of mutations.
AB - Individuals with inflammatory bowel disease (IBD) are at increased risk of developing gastrointestinal cancer. Here, we have tested the possibility that chronic inflammation could trigger mutations. For this, we have used IL-10-deficient (IL-10-/-) mice, which spontaneously develop intestinal inflammation, in combination with a transgenic gpt gene and red/gam gene (gpt+IL- 10-/-), which is a well-characterized mutation reporter locus. The total mutation frequency in the colon of gpt+IL- 10-/- mice was about five times higher than that in normal gpt+IL-10+/+ mice. In the particular case of G:C to A:T transitions, the frequency of mutations in gpt+IL- 10-/- mice was 4.1 times higher than that in control mice. Interestingly, the frequency of small deletions and insertions was also strikingly increased (∼10 times). The majority of the deletion or insertion mutations were observed in the monotonous base runs or adjacent repeats of short tandem sequences. In contrast, the frequency of large deletions, detected by loss of the Spi marker present in the red/gam transgene, was similar among the mouse strains. Finally, as a control, the mutation frequency in non-inflamed tissues, such as the liver, were similar between gpt+IL-10-/- mice and gpt+IL-10+/+ mice. Our data demonstrate that the chronic inflammatory environment in the colon promotes the generation of mutations.
UR - http://www.scopus.com/inward/record.url?scp=33646179267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646179267&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgi327
DO - 10.1093/carcin/bgi327
M3 - Article
C2 - 16407368
AN - SCOPUS:33646179267
SN - 0143-3334
VL - 27
SP - 1068
EP - 1073
JO - Carcinogenesis
JF - Carcinogenesis
IS - 5
ER -